Related Experiment Video
Updated: Jun 22, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Pitfalls, problems, and progress in bronchopulmonary dysplasia
Anita Bhandari1, Vineet Bhandari
1Division of Pediatric Pulmonology, Connecticut Children's Medical Center, Hartford, Connecticut, USA.
Insights
Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants. This review covers recent advances in BPD definition, pathogenesis, biomarkers, and management strategies, alongside long-term outcomes.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Developmental Biology
Background:
- Bronchopulmonary dysplasia (BPD) is a significant complication of preterm birth, characterized by chronic lung injury.
- It affects a substantial number of premature infants, leading to long-term respiratory morbidity.
- Understanding BPD's complexities is crucial for improving infant health outcomes.
Purpose of the Study:
- To review recent advancements in bronchopulmonary dysplasia over the last decade, with a focus on the past five years.
- To critically appraise current and novel management strategies for BPD in human neonates.
- To summarize updated information on pathogenesis, genetic factors, biomarkers, and long-term outcomes of BPD.
Main Methods:
- Comprehensive literature review focusing on studies published within the last 5-10 years.
- Analysis of research concerning human neonates diagnosed with bronchopulmonary dysplasia.
- Synthesis of data on definition changes, pathogenesis, genetic susceptibility, biomarkers, and therapeutic interventions.
Main Results:
- Significant evolution in the definition and understanding of BPD pathogenesis.
- Identification of novel biomarkers aiding in early diagnosis and risk stratification.
- Critical appraisal of established and emerging therapies, highlighting areas of progress and unmet needs.
- Summary of recent findings on the long-term pulmonary and neurodevelopmental sequelae in BPD survivors.
Conclusions:
- Recent progress has refined our understanding and management of bronchopulmonary dysplasia.
- Continued research into pathogenesis, genetics, and novel therapies is essential for further improving outcomes.
- Long-term surveillance is critical for addressing the pulmonary and neurodevelopmental challenges faced by infants with BPD.
Abstract:
Bronchopulmonary dysplasia is a chronic lung disease associated with premature birth and characterized by early lung injury. In this review we discuss some pitfalls, problems, and progress in this condition over the last decade, focusing mainly on the last 5 years, limited to studies in human neonates. Changes in the definition, pathogenesis, genetic susceptibility, and recent biomarkers associated with bronchopulmonary dysplasia will be discussed. Progress in current management strategies, along with novel approaches/therapies, will be critically appraised. Finally, recent data on long-term pulmonary and neurodevelopmental outcomes of infants with bronchopulmonary dysplasia will be summarized.
Related Concept Videos
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Breathing
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: